by Saint Louis University Credit: Pixabay/CC0 Public Domain Researchers at Saint Louis University’s School of Medicine, in collaboration with Arrowhead Pharmaceuticals and Takeda Pharmaceuticals, report the first effective drug to treat a rare, genetic liver disease that formerly could only be treated with a liver transplant. The study, “Fazirsiran for Liver Disease Associated with Alpha1-Antitrypsin...
